About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Manhattan BioSolutions Enters into a Research Collaboration And License Option Agreement with Binghamton University for the New Linker-Payload Technology

NEW YORK, NY / ACCESSWIRE / June 1, 2022 / Manhattan BioSolutions, Inc., an emerging biotechnology company developing new classes of therapeutic biologics for the treatment of advanced and metastatic cancers, today announced a multitarget research and development collaboration and license option agreement with Binghamton University. The collaboration will utilize novel immune-stimulatory linker-payload technology invented at Binghamton University to develop novel antibody-drug conjugates (ADCs) for oncology applications.

The lead investigator is Dr. L. Nathan Tumey, an Assistant Professor in the School of Pharmacy and Pharmaceutical Sciences. Dr. Tumey is a world-class expert in linker-payload chemistry and ADC design, who joined Binghamton University following a long career as a medicinal chemist in the pharmaceutical industry, most recently at Pfizer. Manhattan BioSolutions will have an exclusive option to license global rights for selected linker-payload - antibody combinations targeting distinct tumor-associated antigens.

In addition to the collaboration, Dr Tumey has joined Manhattan BioSolutions's Scientific Advisory Board.

Dr. Borys Shor, Chief Executive Officer, Manhattan BioSolutions commented: "This agreement comes as we continue to build out our preclinical pipeline of novel biologics. It enables us to combine our proprietary antibodies with non-cytotoxic payloads designed to specifically activate innate immune pathways in hematological or in solid tumors. Due to his expertise in medicinal chemistry, Dr Tumey's laboratory will be a key partner to bringing innovative linker-payload technology into our development pipeline."

Dr. Tumey added: "We are excited to be partnering with Manhattan BioSolutions in order to advance a number of innovative preclinical immune-stimulating ADC programs. We believe that the combination of our proprietary ADC technology and Manhattan Biosolution's novel tumor targeting antibodies will produce candidate medicines with unique biological properties. We are particularly excited about developing non-cytotoxic ADCs that may have an improved safety profile as compared to traditional ADC technology."

About Manhattan BioSolutions

Manhattan BioSolutions, Inc. is a privately held biotechnology company focused on the development of biologic immunotherapies that target microbial recognition and host defense pathways for the treatment of advanced cancers. The company has established partnerships with the Stony Brook University, The University at Buffalo, INSERM, EVQLV and has been awarded grants by the National Institutes of Health (NIH), the National Science Foundation (NSF), the New Jersey Commission on Science, Innovation and Technology (CSIT) and the University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UBCAT). Learn more at manhattanbiosolutions.com.

About Binghamton University

Binghamton University, also known as the State University of New York at Binghamton, is one of four doctoral granting research universities in the SUNY system. It is ranked as an "R1" university according to the Carnegie classification, with annual research expenditures exceeding $40 million. The School of Pharmacy and Pharmaceutical Sciences, a research-intensive pharmacy school established in 2016, has rapidly become a hub of health-sciences research for Binghamton University and the Southern Tier of New York.

Contact for investor inquiries:

Jordana Lovett, PhD
Director of Investor Relations
ir@manhattanbiosolutions.com
(857) 600-1021

SOURCE: Manhattan BioSolutions, Inc.



View source version on accesswire.com:
https://www.accesswire.com/703518/Manhattan-BioSolutions-Enters-into-a-Research-Collaboration-And-License-Option-Agreement-with-Binghamton-University-for-the-New-Linker-Payload-Technology

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.